{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:30:57Z","timestamp":1791595857397,"version":"4.3.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MSD avenir; ANRS MIE"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69720-6","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:35:31Z","timestamp":1772210131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Post-treatment SIV control is associated with specific features of viral persistence before and after treatment interruption"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4356-5146","authenticated-orcid":false,"given":"Caroline","family":"Charre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-0201","authenticated-orcid":false,"given":"Adeline","family":"Melard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Chaillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4654-142X","authenticated-orcid":false,"given":"Elise","family":"Gardiennet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5820-3914","authenticated-orcid":false,"given":"Delphine","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-2521","authenticated-orcid":false,"given":"Caroline","family":"Passaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Fillion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastasia","family":"Dimant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8599-2146","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Monceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6682-6313","authenticated-orcid":false,"given":"Nathalie","family":"Dereuddre-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3854-2396","authenticated-orcid":false,"given":"Michaela","family":"Muller-Trutwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rouzioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4928-4484","authenticated-orcid":false,"given":"Roger","family":"Le Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-7536","authenticated-orcid":false,"given":"Asier","family":"Saez- Cirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-2990","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Avettand-Fenoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"69720_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/CMR.00015-16","volume":"29","author":"V Avettand-F\u00e8no\u00ebl","year":"2016","unstructured":"Avettand-F\u00e8no\u00ebl, V. et al. Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications. Clin. Microbiol. Rev. 29, 859\u2013880 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"69720_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/QAD.0000000000000987","volume":"30","author":"R Calin","year":"2016","unstructured":"Calin, R. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir. AIDS 30, 761\u2013769 (2016).","journal-title":"AIDS"},{"key":"69720_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/cid\/ciab541","volume":"74","author":"JZ Li","year":"2022","unstructured":"Li, J. Z. Time to viral rebound after interruption of modern antiretroviral therapies. Clin. Infect. Dis. 74, 865\u2013870 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"69720_CR4","first-page":"343","volume":"30","author":"JZ Li","year":"2016","unstructured":"Li, J. Z. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS 30, 343\u2013353 (2016).","journal-title":"AIDS"},{"key":"69720_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","volume":"278","author":"JK Wong","year":"1997","unstructured":"Wong, J. K. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291\u20131295 (1997).","journal-title":"Science"},{"key":"69720_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont, N. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893\u2013900 (2009).","journal-title":"Nat. Med."},{"key":"69720_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","volume":"21","author":"B Hiener","year":"2017","unstructured":"Hiener, B. et al. Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants. Cell Rep. 21, 813\u2013822 (2017).","journal-title":"Cell Rep."},{"key":"69720_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/387183a0","volume":"387","author":"T-W Chun","year":"1997","unstructured":"Chun, T.-W. et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183\u2013188 (1997).","journal-title":"Nature"},{"key":"69720_CR9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/nm1295-1284","volume":"1","author":"T-W Chun","year":"1995","unstructured":"Chun, T.-W. et al. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1, 1284\u20131290 (1995).","journal-title":"Nat. Med."},{"key":"69720_CR10","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","volume":"94","author":"TW Chun","year":"1997","unstructured":"Chun, T. W. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94, 13193\u201313197 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69720_CR11","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1172\/JCI93289","volume":"127","author":"GQ Lee","year":"2017","unstructured":"Lee, G. Q. et al. Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells. J. Clin. Investig. 127, 2689\u20132696 (2017).","journal-title":"J. Clin. Investig."},{"key":"69720_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho, Y. C. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540\u2013551 (2013).","journal-title":"Cell"},{"key":"69720_CR13","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295\u20131300 (1997).","journal-title":"Science"},{"key":"69720_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/COH.0000000000000891","volume":"20","author":"C Charre","year":"2025","unstructured":"Charre, C., Merad, Y. & Avettand-Fenoel, V. HIV-1 reservoir landscape of post-treatment control. Curr. Opin. HIV AIDS 20, 99\u2013108 (2025).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"69720_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003211","volume":"9","author":"A S\u00e1ez-Ciri\u00f3n","year":"2013","unstructured":"S\u00e1ez-Ciri\u00f3n, A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 9, e1003211 (2013).","journal-title":"PLoS Pathog"},{"key":"69720_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56116-1","volume":"16","author":"JD Gunst","year":"2025","unstructured":"Gunst, J. D. et al. Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies. Nat. Commun. 16, 906 (2025).","journal-title":"Nat. Commun."},{"key":"69720_CR17","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/infdis\/jiy479","volume":"218","author":"G Namazi","year":"2018","unstructured":"Namazi, G. et al. The control of HIV after antiretroviral medication pause (CHAMP) study: Posttreatment Controllers Identified From 14 Clinical Studies. J. Infect. Dis. 218, 1954\u20131963 (2018).","journal-title":"J. Infect. Dis."},{"key":"69720_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S2055-6640(20)30250-8","volume":"4","author":"JM Murray","year":"2018","unstructured":"Murray, J. M. Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy. J. Virus Erad. 4, 91\u201398 (2018).","journal-title":"J. Virus Erad."},{"key":"69720_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44389-3","volume":"15","author":"C Passaes","year":"2024","unstructured":"Passaes, C. et al. Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells. Nat. Commun. 15, 178 (2024).","journal-title":"Nat. Commun."},{"key":"69720_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54783-0","volume":"15","author":"MB Daly","year":"2024","unstructured":"Daly, M. B. et al. SHIV remission in macaques with early treatment initiation and ultra long-lasting antiviral activity. Nat. Commun. 15, 10550 (2024).","journal-title":"Nat. Commun."},{"key":"69720_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/jac\/dks533","volume":"68","author":"L Hocqueloux","year":"2013","unstructured":"Hocqueloux, L. et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J. Antimicrob. Chemother. 68, 1169\u20131178 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"69720_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","volume":"24","author":"DJ Colby","year":"2018","unstructured":"Colby, D. J. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat. Med. 24, 923\u2013926 (2018).","journal-title":"Nat. Med."},{"key":"69720_CR23","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1097\/QAD.0000000000000734","volume":"29","author":"L Assoumou","year":"2015","unstructured":"Assoumou, L. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control. AIDS 29, 2003\u20132007 (2015).","journal-title":"AIDS"},{"key":"69720_CR24","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1073\/pnas.0611244104","volume":"104","author":"A S\u00e1ez-Ciri\u00f3n","year":"2007","unstructured":"S\u00e1ez-Ciri\u00f3n, A. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. USA 104, 6776\u20136781 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69720_CR25","unstructured":"Etemad, B. HIV post-treatment controllers have distinct immunological and virological features. Proc. Natl. Acad. Sci. USA 120, e2218960120 (2023)."},{"key":"69720_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9495","volume":"6","author":"J Hurst","year":"2015","unstructured":"Hurst, J. Immunological biomarkers predict HIV-1 viral rebound after treatment interruption. Nat. Commun. 6, 8495 (2015).","journal-title":"Nat. Commun."},{"key":"69720_CR27","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1097\/QAD.0b013e32830fbdbc","volume":"22","author":"V Avettand-Fenoel","year":"2008","unstructured":"Avettand-Fenoel, V. et al. HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors. AIDS Lond. Engl. 22, 1880\u20131882 (2008).","journal-title":"AIDS Lond. Engl."},{"key":"69720_CR28","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.1128\/JVI.00684-16","volume":"90","author":"R Rose","year":"2016","unstructured":"Rose, R. et al. HIV maintains an evolving and dispersed population in multiple tissues during suppressive combined antiretroviral therapy in individuals with cancer. J. Virol. 90, 8984\u20138993 (2016).","journal-title":"J. Virol."},{"key":"69720_CR29","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1128\/JVI.00674-16","volume":"90","author":"SL Lamers","year":"2016","unstructured":"Lamers, S. L. et al. HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads. J. Virol. 90, 8968\u20138983 (2016).","journal-title":"J. Virol."},{"key":"69720_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.chom.2019.08.003","volume":"26","author":"M-A De Scheerder","year":"2019","unstructured":"De Scheerder, M.-A. et al. HIV rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs. Cell Host Microbe. 26, 347\u2013358.e7 (2019).","journal-title":"Cell Host Microbe"},{"key":"69720_CR31","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1172\/JCI134815","volume":"130","author":"A Chaillon","year":"2020","unstructured":"Chaillon, A. et al. HIV persists throughout deep tissues with repopulation from multiple anatomical sources. J. Clin. Investig. 130, 1699\u20131712 (2020).","journal-title":"J. Clin. Investig."},{"key":"69720_CR32","doi-asserted-by":"publisher","first-page":"113053","DOI":"10.1016\/j.celrep.2023.113053","volume":"42","author":"C Dufour","year":"2023","unstructured":"Dufour, C. et al. Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART. Cell Rep. 42, 113053 (2023).","journal-title":"Cell Rep"},{"key":"69720_CR33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.it.2007.08.009","volume":"28","author":"VV Ganusov","year":"2007","unstructured":"Ganusov, V. V. & De Boer, R. J. Do most lymphocytes in humans really reside in the gut?. Trends Immunol. 28, 514\u2013518 (2007).","journal-title":"Trends Immunol."},{"key":"69720_CR34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1086\/527324","volume":"197","author":"T-W Chun","year":"2008","unstructured":"Chun, T.-W. et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 197, 714\u2013720 (2008).","journal-title":"J. Infect. Dis."},{"key":"69720_CR35","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/infdis\/jit308","volume":"208","author":"SA Yukl","year":"2013","unstructured":"Yukl, S. A. et al. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J. Infect. Dis. 208, 1212\u20131220 (2013).","journal-title":"J. Infect. Dis."},{"key":"69720_CR36","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes, J. D. et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat. Med. 23, 1271\u20131276 (2017).","journal-title":"Nat. Med."},{"key":"69720_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav3491","volume":"12","author":"L Leyre","year":"2020","unstructured":"Leyre, L. et al. Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection. Sci. Transl. Med. 12, eaav3491 (2020).","journal-title":"Sci. Transl. Med."},{"key":"69720_CR38","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1128\/JVI.77.23.12479-12493.2003","volume":"77","author":"K Benlhassan-Chahour","year":"2003","unstructured":"Benlhassan-Chahour, K. Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy. J Virol 77, 12479\u201312493 (2003).","journal-title":"J Virol"},{"key":"69720_CR39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.chom.2023.01.016","volume":"31","author":"EJ Fray","year":"2023","unstructured":"Fray, E. J. et al. Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants. Cell Host Microbe. 31, 356\u2013372.e5 (2023).","journal-title":"Cell Host Microbe"},{"key":"69720_CR40","doi-asserted-by":"crossref","unstructured":"Mannioui, A. Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques. Retrovirology 6, 106, (2009).","DOI":"10.1186\/1742-4690-6-106"},{"key":"69720_CR41","doi-asserted-by":"crossref","unstructured":"Policicchio, B. B., Pandrea, I. & Apetrei, C. Animal models for HIV cure research. Front. Immunol. 7, 12 (2016).","DOI":"10.3389\/fimmu.2016.00012"},{"key":"69720_CR42","doi-asserted-by":"publisher","first-page":"e1007222","DOI":"10.1371\/journal.ppat.1007222","volume":"14","author":"P Goulder","year":"2018","unstructured":"Goulder, P. & Deeks, S. G. HIV control: Is getting there the same as staying there?. PLOS Pathog. 14, e1007222 (2018).","journal-title":"PLOS Pathog"},{"key":"69720_CR43","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/jac\/dkab060","volume":"76","author":"A Mastrangelo","year":"2021","unstructured":"Mastrangelo, A. et al. Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study). J. Antimicrob. Chemother. 76, 1646\u20131648 (2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"69720_CR44","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/mi.2013.127","volume":"7","author":"KC Jambo","year":"2014","unstructured":"Jambo, K. C. et al. Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol. 7, 1116\u20131126 (2014).","journal-title":"Mucosal Immunol"},{"key":"69720_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2249.1994.tb06539.x","volume":"96","author":"JR Clarke","year":"1994","unstructured":"Clarke, J. R. et al. HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients. Clin. Exp. Immunol. 96, 182\u2013186 (1994).","journal-title":"Clin. Exp. Immunol."},{"key":"69720_CR46","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1097\/QAD.0000000000001962","volume":"32","author":"CT Costiniuk","year":"2018","unstructured":"Costiniuk, C. T. et al. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy. AIDS Lond. Engl. 32, 2279\u20132289 (2018).","journal-title":"AIDS Lond. Engl."},{"key":"69720_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1681\/ASN.2013050564","volume":"25","author":"G Canaud","year":"2014","unstructured":"Canaud, G. et al. The kidney as a reservoir for HIV-1 after renal transplantation. J. Am. Soc. Nephrol. 25, 407\u2013419 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"69720_CR48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/QAD.0000000000002753","volume":"35","author":"K Hughes","year":"2021","unstructured":"Hughes, K. et al. HIV-1 infection of the kidney: mechanisms and implications. AIDS 35, 359\u2013367 (2021).","journal-title":"AIDS"},{"key":"69720_CR49","doi-asserted-by":"publisher","first-page":"e00624","DOI":"10.1128\/jvi.00624-22","volume":"96","author":"EJ Baker","year":"2022","unstructured":"Baker, E. J., Hughes, K., Travieso, T., Klotman, M. E. & Blasi, M. Establishment, persistence, and reactivation of latent HIV-1 infection in renal epithelial cells. J. Virol. 96, e00624\u201322 (2022).","journal-title":"J. Virol."},{"key":"69720_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03267-22","volume":"11","author":"P Tr\u00e9meaux","year":"2023","unstructured":"Tr\u00e9meaux, P. et al. In-depth characterization of full-length archived viral genomes after nine years of posttreatment HIV control. Microbiol. Spectr. 11, e0326722 (2023).","journal-title":"Microbiol. Spectr."},{"key":"69720_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw5589","volume":"11","author":"M-R Abrahams","year":"2019","unstructured":"Abrahams, M.-R. et al. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation. Sci. Transl. Med. 11, eaaw5589 (2019).","journal-title":"Sci. Transl. Med."},{"key":"69720_CR52","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.it.2022.06.002","volume":"43","author":"M Lichterfeld","year":"2022","unstructured":"Lichterfeld, M., Gao, C. & Yu, X. G. An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection. Trends Immunol 43, 608\u2013616 (2022).","journal-title":"Trends Immunol"},{"key":"69720_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21724-0","volume":"12","author":"AM Cadena","year":"2021","unstructured":"Cadena, A. M. et al. Persistence of viral RNA in lymph nodes in ART-suppressed SIV\/SHIV-infected Rhesus Macaques. Nat. Commun. 12, 1474 (2021).","journal-title":"Nat. Commun."},{"key":"69720_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi9867","volume":"15","author":"A Solis-Leal","year":"2023","unstructured":"Solis-Leal, A. et al. Lymphoid tissues contribute to plasma viral clonotypes early after antiretroviral therapy interruption in SIV-infected rhesus macaques. Sci. Transl. Med. 15, eadi9867 (2023).","journal-title":"Sci. Transl. Med."},{"key":"69720_CR55","doi-asserted-by":"publisher","first-page":"108174","DOI":"10.1016\/j.celrep.2020.108174","volume":"32","author":"C Passaes","year":"2020","unstructured":"Passaes, C. Optimal maturation of the SIV-specific CD8+ T cell response after primary infection is associated with natural control of SIV: ANRS SIC study. Cell Rep 32, 108174 (2020).","journal-title":"Cell Rep"},{"key":"69720_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23189-7","volume":"12","author":"J Harper","year":"2021","unstructured":"Harper, J. IL-21 and IFNalpha therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques. Nat Commun. 12, 2866 (2021).","journal-title":"Nat Commun"},{"key":"69720_CR57","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2352-3018(22)00302-2","volume":"10","author":"N Climent","year":"2023","unstructured":"Climent, N. et al. Immunological and virological findings in a patient with exceptional post-treatment control: a case report. Lancet HIV 10, e42\u2013e51 (2023).","journal-title":"Lancet HIV"},{"key":"69720_CR58","doi-asserted-by":"publisher","unstructured":"Essat, A. et al. A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI\/PRIMO. Med 100670 https:\/\/doi.org\/10.1016\/j.medj.2025.100670 (2025).","DOI":"10.1016\/j.medj.2025.100670"},{"key":"69720_CR59","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41579-024-01010-8","volume":"22","author":"M Armani-Tourret","year":"2024","unstructured":"Armani-Tourret, M. et al. Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure. Nat. Rev. Microbiol. 22, 328\u2013344 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"69720_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.chom.2022.12.002","volume":"31","author":"X Lian","year":"2023","unstructured":"Lian, X. et al. Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. Cell Host Microbe. 31, 83\u201396.e5 (2023).","journal-title":"Cell Host Microbe"},{"key":"69720_CR61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173864","volume":"9","author":"JZ Li","year":"2024","unstructured":"Li, J. Z. et al. Predictors of HIV rebound differ by timing of antiretroviral therapy initiation. JCI Insight 9, e173864 (2024).","journal-title":"JCI Insight"},{"key":"69720_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/COH.0000000000000898","volume":"20","author":"FS Mesquita","year":"2025","unstructured":"Mesquita, F. S., Li, Y. & Li, J. Z. Viral and immune predictors of HIV posttreatment control. Curr. Opin. HIV AIDS 20, 54\u201360 (2025).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"69720_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/COH.0000000000000889","volume":"20","author":"LB Giron","year":"2025","unstructured":"Giron, L. B., Pasternak, A. O. & Abdel-Mohsen, M. Soluble markers of viral rebound and post-treatment HIV control. Curr. Opin. HIV AIDS 20, 61\u201369 (2025).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"69720_CR64","doi-asserted-by":"publisher","first-page":"0125422","DOI":"10.1128\/jvi.01254-22","volume":"97","author":"A Wedrychowski","year":"2023","unstructured":"Wedrychowski, A. Transcriptomic signatures of human immunodeficiency virus post-treatment control. J. Virol. 97, 0125422 (2023).","journal-title":"J. Virol."},{"key":"69720_CR65","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1089\/08892220050117014","volume":"16","author":"R Hofmann-Lehmann","year":"2000","unstructured":"Hofmann-Lehmann, R. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res. Hum. Retroviruses. 16, 1247\u20131257 (2000).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"69720_CR66","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","volume":"566","author":"KM Bruner","year":"2019","unstructured":"Bruner, K. M. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566, 120\u2013125 (2019).","journal-title":"Nature"},{"key":"69720_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.chom.2019.06.005","volume":"26","author":"AM Bender","year":"2019","unstructured":"Bender, A. M. et al. The landscape of persistent viral genomes in ART-Treated SIV, SHIV, and HIV-2 infections. Cell Host Microbe. 26, 73\u201385.e4 (2019).","journal-title":"Cell Host Microbe"},{"key":"69720_CR68","doi-asserted-by":"publisher","first-page":"e02100","DOI":"10.1128\/JVI.02100-17","volume":"92","author":"BB Policicchio","year":"2018","unstructured":"Policicchio, B. B. et al. Dynamics of simian immunodeficiency virus two-long-terminal-repeat circles in the presence and absence of CD8+ cells. J. Virol. 92, e02100\u2013e02117 (2018).","journal-title":"J. Virol."},{"key":"69720_CR69","doi-asserted-by":"publisher","first-page":"100243","DOI":"10.1016\/j.xcrm.2021.100243","volume":"2","author":"CN Levy","year":"2021","unstructured":"Levy, C. N. et al. A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir. Cell Rep. Med. 2, 100243 (2021).","journal-title":"Cell Rep. Med."},{"key":"69720_CR70","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/bioinformatics\/btac089","volume":"38","author":"D Cai","year":"2022","unstructured":"Cai, D. & Sun, Y. Reconstructing viral haplotypes using long reads. Bioinform. Oxf. Engl. 38, 2127\u20132134 (2022).","journal-title":"Bioinform. Oxf. Engl."},{"key":"69720_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08431-7","volume":"10","author":"MR Pinzone","year":"2019","unstructured":"Pinzone, M. R. et al. Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion. Nat. Commun. 10, 728 (2019).","journal-title":"Nat. Commun."},{"key":"69720_CR72","doi-asserted-by":"publisher","unstructured":"Tamura, K. & Nei, M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol.https:\/\/doi.org\/10.1093\/oxfordjournals.molbev.a040023 (1993).","DOI":"10.1093\/oxfordjournals.molbev.a040023"},{"key":"69720_CR73","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/molbev\/msu300","volume":"32","author":"L-T Nguyen","year":"2015","unstructured":"Nguyen, L.-T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268\u2013274 (2015).","journal-title":"Mol. Biol. Evol."},{"key":"69720_CR74","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nprot.2010.73","volume":"5","author":"A S\u00e1ez-Ciri\u00f3n","year":"2010","unstructured":"S\u00e1ez-Ciri\u00f3n, A., Shin, S. Y., Versmisse, P., Barr\u00e9-Sinoussi, F. & Pancino, G. Ex vivo T cell\u2013based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nat. Protoc. 5, 1033\u20131041 (2010).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69720-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:04:48Z","timestamp":1775732688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69720"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69720-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C. honoraria and travel grants from MSD, ViiV Healthcare and Gilead Sciences for participation in educational programs and conferences. A.S.C. has received speaker fees from MSD, ViiV Healthcare, Gilead, Janssen. V.A.F. has received grants (to her institution) from ViiV Healthcare and honoraria and travel grants from ViiV Healthcare and Gilead Sciences for participation in educational programs and conferences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3290"}}